Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


17.12.2018

1 AJR Am J Roentgenol
2 Ann Intern Med
2 Clin Gastroenterol Hepatol
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
2 Gastroenterology
5 Inflamm Bowel Dis
6 J Crohns Colitis
2 Proc Natl Acad Sci U S A
2 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. PUYLAERT CAJ, Nolthenius CJT, Tielbeek JAW, Makanyanga JC, et al
    Comparison of MRI Activity Scoring Systems and Features for the Terminal Ileum in Patients With Crohn Disease.
    AJR Am J Roentgenol. 2018 Dec 12:W1-W7. doi: 10.2214/AJR.18.19876.
    PubMed     Text format     Abstract available


    Ann Intern Med

  2. NIELSEN OH, Ainsworth MA
    Biosimilars for Management of Crohn Disease.
    Ann Intern Med. 2018 Dec 11. pii: 2718686. doi: 10.7326/M18-3060.
    PubMed     Text format    

  3. MEYER A, Rudant J, Drouin J, Weill A, et al
    Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease: A French Equivalence Study.
    Ann Intern Med. 2018 Dec 11. pii: 2718685. doi: 10.7326/M18-1512.
    PubMed     Text format     Abstract available


    Clin Gastroenterol Hepatol

  4. WEAVER KN, Long MD
    Preventive Medicine in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2018 Dec 6. pii: S1542-3565(18)31331.
    PubMed     Text format     Abstract available

  5. MA C, Kotze PG, Almutairdi A, Jairath V, et al
    Concomitant Use of Aminosalicylates Is Not Associated with Improved Outcomes in Patients with Ulcerative Colitis Escalated to Vedolizumab.
    Clin Gastroenterol Hepatol. 2018 Dec 7. pii: S1542-3565(18)31341.
    PubMed     Text format    


    Dig Dis Sci

  6. LEWIN SM, Wen KW, Velayos FS, Mahadevan U, et al
    How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Dec 7. pii: 10.1007/s10620-018-5409.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  7. ORFANOUDAKI E, Gazouli M, Foteinogiannopoulou K, Theodoraki E, et al
    Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab.
    Eur J Gastroenterol Hepatol. 2018 Dec 12. doi: 10.1097/MEG.0000000000001332.
    PubMed     Text format     Abstract available


    Gastroenterology

  8. PARAMSOTHY S, Nielsen S, Kamm MA, Deshpande NP, et al
    Specific Bacteria and Metabolites Associated with Response to Fecal Microbiota Transplantation in Patients with Ulcerative Colitis.
    Gastroenterology. 2018 Dec 6. pii: S0016-5085(18)35387.
    PubMed     Text format     Abstract available

  9. BIANCHERI P, Watson AJM
    High Mucosal Plasma Cell Numbers and Low Serum TREM-1 Levels May Predict Nonresponsiveness to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.
    Gastroenterology. 2018 Nov 22. pii: S0016-5085(18)35291.
    PubMed     Text format    


    Inflamm Bowel Dis

  10. DEBRUYN JCC, Soon IS, Fonseca K, Feng S, et al
    Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 14. pii: 5247477. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. PABLA BS, Scoville EA, Sarker S, Dalal RL, et al
    Histoplasmosis as a Complication of Inflammatory Bowel Disease Therapy: A Case Series.
    Inflamm Bowel Dis. 2018 Dec 13. pii: 5244945. doi: 10.1093.
    PubMed     Text format    

  12. OBRAZTSOV IV, Shirokikh KE, Obraztsova OI, Shapina MV, et al
    Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2018 Dec 13. pii: 5245415. doi: 10.1093.
    PubMed     Text format     Abstract available

  13. SONG G, Fiocchi C, Achkar JP
    Acupuncture in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 11. pii: 5238704. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. KRISTENSEN MS, Kjaerulff TM, Ersboll AK, Green A, et al
    The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Inflamm Bowel Dis. 2018 Dec 14. pii: 5247629. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  15. LUNDER AK, Bakstad LT, Jahnsen J, Borthne A, et al
    Assessment of Bowel Inflammation and Strictures by Magnetic Resonance Enterography in Long-term Crohn s Disease.
    J Crohns Colitis. 2018 Dec 12. pii: 5240680. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. THOMAS T, Chandan JS, Harvey PR, Bhala N, et al
    The risk of inflammatory bowel disease in subjects presenting with perianal abscess: findings from the THIN database.
    J Crohns Colitis. 2018 Dec 13. pii: 5244181. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. CONRAD MA, Carreon CK, Dawany N, Russo P, et al
    Distinct histopathological features at diagnosis of very early onset inflammatory bowel disease.
    J Crohns Colitis. 2018 Dec 14. pii: 5247350. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. TCYMBAREVICH I, Richards SM, Russo G, Kuhn-Georgijevic J, et al
    Lack of the pH-sensing Receptor TDAG8 [GPR65] in Macrophages Plays a Detrimental Role in Murine Models of Inflammatory Bowel Disease.
    J Crohns Colitis. 2018 Oct 9. pii: 5237755. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. YANAI H, Dotan I
    Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.
    J Crohns Colitis. 2018 Dec 11. pii: 5238056. doi: 10.1093.
    PubMed     Text format    

  20. NUNES G, Patita M, Fernandes V
    Refractory pyoderma gangrenosum in a patient with Crohn s Disease: complete response to Ustekinumab.
    J Crohns Colitis. 2018 Dec 7. pii: 5232612. doi: 10.1093.
    PubMed     Text format    


    Proc Natl Acad Sci U S A

  21. NAGAHAMA Y, Shimoda M, Mao G, Singh SK, et al
    Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism.
    Proc Natl Acad Sci U S A. 2018;115:11036-11041.
    PubMed     Text format     Abstract available

  22. YANG Z, Li Q, Wang X, Jiang X, et al
    C-type lectin receptor LSECtin-mediated apoptotic cell clearance by macrophages directs intestinal repair in experimental colitis.
    Proc Natl Acad Sci U S A. 2018;115:11054-11059.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  23. HOLLERAN G, Valerii G, Tortora A, Scaldaferri F, et al
    The use of single balloon enteroscopy in Crohn's disease and its impact on clinical outcome.
    Scand J Gastroenterol. 2018;53:925-929.
    PubMed     Text format     Abstract available

  24. BUHL S, Kristina Borghede M, Brynskov J, Steenholdt C, et al
    Outcome of continued infliximab therapy in Crohn's disease patients with response but without remission after one year of infliximab - a retrospective cohort study.
    Scand J Gastroenterol. 2018;53:930-937.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: